(Q73515814)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

N Noguchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Nishino

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Niki

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1069-1076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol inhibits vascular smooth muscle cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Mechanisms of free radical oxidation of unsaturated lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol: an effective antihypertensive drug with antiischemic/antioxidant cardioprotective properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol inhibition of lipid peroxidation. A new antioxidative mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

2,2'-Azobis (4-methoxy-2,4-dimethylvaleronitrile), a new lipid-soluble azo initiator: application to oxidations of lipids and low-density lipoprotein in solution and in aqueous dispersions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Antioxidant activities of probucol against lipid peroxidations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Oxidation of methyl linoleate in aqueous dispersions induced by copper and iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Continuous monitoring of in vitro oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Interaction among vitamin C, vitamin E, and beta-carotene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Action of ebselen as an antioxidant against lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Antioxidant effect of Ebselen (PZ 51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900417-7

10.1016/S0006-2952(99)00417-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704936%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference